Your browser doesn't support javascript.
loading
Reduction in the cerebrospinal fluid protein level after bevacizumab treatment in patients with optic pathway low-grade gliomas.
da Costa, Marcos Devanir; Watanabe, Rodrigo Akira; Soares, Carolina Torres; Dassi, Natalia; Dastoli, Patricia Alessandra; Nicácio, Jardel Mendonça; Cappellano, Andrea Maria; Silva, Nasjla Saba; Cavalheiro, Sergio.
  • da Costa MD; Department of Neurology and Neurosurgery, Universidade Federal de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
  • Watanabe RA; Division of Neurosurgery, Instituto de Oncologia Pediatrica (IOP/GRAACC), Sao Paulo, Sao Paulo, Brazil.
  • Soares CT; Department of Neurology and Neurosurgery, Universidade Federal de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
  • Dassi N; Department of Neurology and Neurosurgery, Universidade Federal de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
  • Dastoli PA; Division of Neuro-Oncology, Instituto de Oncologia Pediatrica (IOP/GRAACC), Sao Paulo, Sao Paulo, Brazil.
  • Nicácio JM; Department of Neurology and Neurosurgery, Universidade Federal de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
  • Cappellano AM; Division of Neurosurgery, Instituto de Oncologia Pediatrica (IOP/GRAACC), Sao Paulo, Sao Paulo, Brazil.
  • Silva NS; Department of Neurology and Neurosurgery, Universidade Federal de Sao Paulo, Sao Paulo, Sao Paulo, Brazil.
  • Cavalheiro S; Division of Neurosurgery, Instituto de Oncologia Pediatrica (IOP/GRAACC), Sao Paulo, Sao Paulo, Brazil.
Pediatr Blood Cancer ; 69(5): e29637, 2022 05.
Article en En | MEDLINE | ID: mdl-35233919
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glioma del Nervio Óptico Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glioma del Nervio Óptico Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article